Thursday - November 12, 2026
USC Schaeffer Center for Health Policy: Medicare Plans Rarely Cover Anti-Obesity Drugs for Other FDA-Approved Purposes
November 07, 2026
LOS ANGELES, California, Nov. 7 -- The University of Southern California Schaeffer Center for Health Policy and Economics issued the following news:

* * *

Medicare Plans Rarely Cover Anti-Obesity Drugs for Other FDA-Approved Purposes

November 6, 2026

Expanding uses for GLP-1s have not translated into broader coverage

-

Just a fraction of Medicare prescription drug plans cover anti-obesity medications for other purposes . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products